CONMED interim controller reports equity holdings
CONMED Corporation’s interim corporate controller and principal accounting officer, Kimberly Lockwood, reported her existing equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CONMED Corporation’s interim corporate controller and principal accounting officer, Kimberly Lockwood, reported her existing equity holdings. She directly holds 1,868 shares of common stock, along with multiple grants of restricted stock units and stock options that provide potential future rights to additional common shares.
The RSUs each represent a right to receive one share of CONMED common stock, generally vesting over a three‑year period under the company’s 2025 Long-Term Incentive Plan. The stock options were granted under CONMED’s 2015 and 2018 Long-Term Incentive Plans and typically vest evenly over five years, with exercise prices ranging from $58.33 to $144.55 per share and expirations between 2028 and 2035.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | RSUs (Restricted Stock Units) | -- | -- | -- |
| holding | RSUs (Restricted Stock Units) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- F2. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- F3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
Key Figures
Key Terms
Restricted Stock Units financial
Long-Term Incentive Plan financial
Options To Purchase Common Stock financial
vest financial
restricted stock unit ("RSU") financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CONMED (CNMD) interim controller Kimberly Lockwood report in this Form 3/A?
What restricted stock unit (RSU) positions are disclosed for CONMED (CNMD)?
What stock options does Kimberly Lockwood hold in CONMED (CNMD)?
Under which incentive plans were the CONMED (CNMD) options and RSUs granted?
How do the CONMED (CNMD) RSUs described in the filing vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.